靶点- |
|
|
|
在研适应症- |
非在研适应症- |
最高研发阶段临床1/2期 |
首次获批国家/地区- |
首次获批日期- |
Long-Term Safety Study of CTX0E03 in Subjects Who Completed PISCES III Study
The purpose of this long-term safety study is to follow up subjects treated with CTX0E03 DP to monitor for delayed oncological, neurological, and CTX0E03 DP-related adverse events and to monitor survival
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke
A study of stereotactic, intracerebral injection of CTX0E03 neural stem cells into patients with moderate to moderately severe disability as a result of an ischemic stroke.
A Non-interventional Observational Clinical Study to Document the Clinical Course of Patients 12 Months or More Following an Ischaemic Stroke
A non-interventional observational clinical study to document the clinical course of patients at 12 months or more following an ischaemic stroke
100 项与 ReNeuron Ltd. 相关的临床结果
0 项与 ReNeuron Ltd. 相关的专利(医药)
100 项与 ReNeuron Ltd. 相关的药物交易
100 项与 ReNeuron Ltd. 相关的转化医学